1.
Schlenk RF. Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia. haematol [Internet]. 2024Jun.1 [cited 2024Jul.15];109(6):1629-30. Available from: https://haematologica.org/article/view/11605